AstraZeneca Plc (NASDAQ: AZN)
AstraZeneca Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AstraZeneca Plc Company Info
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
News & Analysis
The Largest Healthcare Companies by Market Cap in April 2025
Eli Lilly, UnitedHealth Group, and Johnson & Johnson command the healthcare sector.
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Might the tariff risk for pharmaceutical stocks be less than you think?
3 No-Brainer Growth Stocks to Buy for Less Than $100
Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
Investing in ESG ETFs
3 Magnificent Growth Stocks to Buy Right Now
What's a Good Price for AstraZeneca Stock?
Why AstraZeneca Topped the Market on Thursday
Valuation
Podcast Episodes
Talking About Vaccine News, Oil Predictions, and More
Discover why the stock price movement of AstraZeneca may be misleading.
Is Biopharma Immune to Brexit Fallout?
Digesting how the U.K. decision to exit the EU could affect healthcare stocks here and abroad.
Earnings Transcripts
AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript
AZN earnings call for the period ending December 31, 2024.
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
AZN earnings call for the period ending September 30, 2024.
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript
AZN earnings call for the period ending June 30, 2024.
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
AZN earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.